Aerosolized lidocaine does not confer benefit as an add-on therapy to reduce respiratory therapy-associated pain after pediatric congenital heart surgery: a randomized, double-blind, placebo-controlled trial

Detalhes bibliográficos
Ano de defesa: 2021
Autor(a) principal: Silva, Thalis Henrique da
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: eng
Instituição de defesa: Biblioteca Digitais de Teses e Dissertações da USP
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://www.teses.usp.br/teses/disponiveis/17/17144/tde-08092021-164508/
Resumo: Objective: To investigate whether respiratory therapy (RT) increases pain if inhaled lidocaine can attenuate pain increase in infants and children undergoing surgery for congenital heart disease (CHD). Design: Double-blind, randomized, placebo-controlled trial. Setting: Pediatric intensive care unit in a Brazilian tertiary-care, university hospital. Patients: 119 patients < 18 years submitted to open-heart surgery for CHD. Interventions: Aerosolized lidocaine (1 mg/kg) before RT maneuvers and tracheal suction, compared to placebo. Measurements and main results: Pain was assessed by the face, legs, activity, cry, consolability pain scale - revised (FLACC-R), along with hemodynamic and ventilatory parameters, before and after RT and tracheal suction on postoperative days 1, 3, and 7. Lidocaine or placebo were administered right before RT. RT induced minor changes in pain, which were not attenuated by lidocaine (confirmed in multivariate analysis). RT also induced minor, not clinically relevant effects in hemodynamic and ventilatory parameters, which were also not modified by lidocaine. Conclusions: Respiratory therapy did not increase postoperative pain in patients after pediatric congenital heart surgery up to the 7th day, nor aerosolized lidocaine exhibited any clinically significant effect on pain or other hemodynamic or ventilatory parameters.